Heart failure & cardiomyopathiesSecondary analysis
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device
- Secondary analysis of the MOMENTUM 3 randomised trial
Authors' conclusion
Long-term survival in successfully discharged HM3 LVAD recipients is largely influenced by clinical events experienced during the index surgical hospitalization in tandem with baseline factors, with mortality of <50% at 5 years.
Study context
- Population
- Advanced HF patients discharged after HM3 left ventricular assist device (LVAD) implantation, MOMENTUM 3 pivotal trialof 515 (94%) discharged
- Participants
- 485 patients
- Comparison
- No risk predictors vs ≥1 predictor
- No risk predictorsn = 171
- Primary endpoint
- Mortality and its risk predictors
- Follow-up
- 5 years
Primary result
As reported in the abstract
Cumulative 5-year mortality
- Cumulative 5-year mortality, whole cohort
- 38%
Original publication
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. Published 29 August 2023. doi:10.1016/j.jacc.2023.05.066
Summarised from the published abstract; every number is checked against it